These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21829702)

  • 1. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
    Mossman D; Scott RJ
    PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
    Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
    Kondo Y; Shen L; Issa JP
    Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
    Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
    Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.
    Fatemi M; Paul TA; Brodeur GM; Shokrani B; Brim H; Ashktorab H
    Cancer; 2014 Jan; 120(2):172-80. PubMed ID: 24243398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histone H3 lysine 9 methylation is associated with the expression of hMLH1 and DNA methylation in gastric cancer cells].
    Meng CF; Zhu XJ; Peng G
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2490-3. PubMed ID: 19080631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
    Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
    Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
    Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation.
    Dannenberg LO; Edenberg HJ
    BMC Genomics; 2006 Jul; 7():181. PubMed ID: 16854234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A; Santini V
    Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
    Lambrot R; Kimmins S
    Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.